Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−99.5x

Market Cap

$261.22M

MomentumView details →

1D Return

+0.00%

YTD Return

+3.76%

RSI (14)

65.2

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−99.5x

Market Cap

$261.22M

RSI (14)

65.2

MomentumView details →

1D Return

+0.00%

YTD Return

+3.76%

ProfitabilityView details →

Gross Margin

—

Net Margin

—

EBITDA Margin

—

ROE (TTM)

4.42%

ROA (TTM)

4.15%

Asset Turnover

0.00x

GrowthView details →

Revenue YoY

—

EPS YoY

−99.85%

FCF YoY

+46.96%

Revenue CAGR 3Y

—

EPS CAGR 3Y

+439.29%

EBITDA YoY

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.01x

Current Ratio

0.02x

Quick Ratio

0.02x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

Financials snapshotView financials →

Revenue (TTM)

0.00

Net Income (TTM)

6.09M

Op. CF (TTM)

−323129.00

Latest newsMore news →

No recent news for DMAA.

Similar companies

Launch One Acquisition Corp. UnitLPAAU FACT II Acquisition CorpFACT Newbury Street II Acquisition CorpNTWO Vendome Acquisition Corporation IVNME SIM Acquisition Corp. I UnitSIMAU Lafayette Digital Acquisition Corp. I UnitZKPU Find similar companies →

Latest newsMore news →

No recent news for DMAA.